Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950 · see citing works

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461 · see citing works

PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSES

Dulbecco, R., & Vogt, M. (1954) · The Journal of Experimental Medicine · doi:10.1084/jem.99.2.167 · Cited by 3,837 · see citing works

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,191 · see citing works

The NCI60 human tumour cell line anticancer drug screen

Shoemaker, R. H. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1951 · Cited by 2,644 · see citing works

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278 · see citing works

MDM2, MDMX and p53 in oncogenesis and cancer therapy

Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279 · see citing works

A small-cell lung cancer genome with complex signatures of tobacco exposure

Pleasance, E., Stephens, P. J., O’Meara, S., McBride, D. J., Meynert, A. M., Jones, D., Lin, M., Beare, D. M., Lau, K. W., Greenman, C., et al. (2009) · Nature · doi:10.1038/nature08629 · Cited by 1,067 · see citing works

p53 mutations in colorectal cancer.

Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J., & Lane, D. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7555 · Cited by 1,002 · see citing works

Untitled work

(1952) · Cancer Research · Cited by 987 · see citing works

Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., Mutoh, M., Scudiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N., et al. (1997) · PubMed · Cited by 867 · see citing works

p53 isoforms can regulate p53 transcriptional activity

Bourdon, J.-C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K., & Lane, D. P. (2005) · Genes & Development · doi:10.1101/gad.1339905 · Cited by 810 · see citing works

Signatures of mutation and selection in the cancer genome

Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707 · see citing works

Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.

Isaacs, W. B., Carter, B. S., & Ewing, C. M. (1991) · PubMed · Cited by 439 · see citing works

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set

Ikediobi, O. N., Davies, H. R., Bignell, G. R., Edkins, S., Stevens, C., O’Meara, S., Santarius, T., Avis, T., Barthorpe, S., Brackenbury, L., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0433 · Cited by 433 · see citing works

MDA-MB-435 cells are derived from M14 Melanoma cells––a loss for breast cancer, but a boon for melanoma research

Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9392-8 · Cited by 374 · see citing works

Cross-contamination of cells in culture

Nelson-Rees, W. A., Daniels, D. W., & Flandermeyer, R. R. (1981) · Science · doi:10.1126/science.6451928 · Cited by 329 · see citing works

Global Proteome Analysis of the NCI-60 Cell Line Panel

Gholami, A. M., Hahne, H., Wu, Z., Auer, F. J., Meng, C., Wilhelm, M., & Kuster, B. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.018 · Cited by 302 · see citing works

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology

Abaan, O. D., Polley, E. C., Davis, S. R., Zhu, Y. J., Bilke, S., Walker, R. L., Pineda, M., Gindin, Y., Jiang, Y., Reinhold, W. C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3342 · Cited by 288 · see citing works

Cell line misidentification: the beginning of the end

American Type Culture Collection Standards Development Organization Workgroup ASN-0002 (2010) · Nature Reviews Cancer · doi:10.1038/nrc2852 · Cited by 266 · see citing works

Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research

Gazdar, A. F., Girard, L., Lockwood, W. W., Lam, W. L., & Minna, J. D. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq279 · Cited by 240 · see citing works

RAD001 Inhibits Human Ovarian Cancer Cell Proliferation, Enhances Cisplatin-Induced Apoptosis, and Prolongs Survival in an Ovarian Cancer Model

Mabuchi, S., Altomare, D. A., Cheung, M., Zhang, L., Poulikakos, P. I., Hensley, H. H., Schilder, R. J., Ozols, R. F., & Testa, J. R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2770 · Cited by 233 · see citing works

MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?

Chambers, A. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1528 · Cited by 218 · see citing works

A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells

Liscovitch, M., & Ravid, D. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.01.013 · Cited by 152 · see citing works

p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.

Debernardis, D., Siré, E. G., de Feudis, P., Vikhanskaya, F., Valenti, M., Russo, P., Parodi, S., D’Incalci, M., & Broggini, M. (1997) · PubMed · Cited by 146 · see citing works

Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines.

Cottu, P. H., Muzeau, F., Estreicher, A., Fléjou, J., Iggo, R. D., Thomas, G. D., & Hamelin, R. (1996) · PubMed · Cited by 104 · see citing works

Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination

Berglind, H., Yudi Pawitan, Y., Kato, S., Ishioka, C., & Soussi, T. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.5.5712 · Cited by 102 · see citing works

Cell Line Designation Change: Multidrug-Resistant Cell Line in the NCI Anticancer Screen

Scudiero, D. A., Monks, A. P., & Sausville, E. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.862 · Cited by 96 · see citing works

Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.

Kropveld, A., Rozemuller, E. H., de Straat, F. G. J. L.-V., Scheidel, K. C., de Weger, R. A., Koole, R., Hordijk, G. J., Slootweg, P. J., & Tilanus, M. G. J. (1999) · PubMed · Cited by 90 · see citing works

p53 alterations in human leukemia–lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?

Drexler, H. G., Fombonne, S., Matsuo, Y., Hu, Z.-B., Hamaguchi, H., & Uphoff, C. (2000) · Leukemia · doi:10.1038/sj.leu.2401604 · Cited by 71 · see citing works

Overexpression and mutations of p53 in metastatic malignant melanomas

Hartmann, A., Blaszyk, H., Cunningham, J. S., McGovern, R. M., Jj, S., Helander, S. D., Pittelkow, M. R., Sommer, S. S., & Kovach, J. S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960729)67:3 · Cited by 63 · see citing works

Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line

Chow, V. T. K., Quek, H. H., & Tock, E. P. C. (1993) · Cancer Letters · doi:10.1016/0304-3835(93)90256-9 · Cited by 59 · see citing works

Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region

Hauser, U., Balz, V., Carey, T. E., Grenman, R. A., Lierop, A. V., Scheckenbach, K., & Bier, H. (2002) · Head & Neck · doi:10.1002/hed.10128 · Cited by 48 · see citing works

Copy-Neutral Loss of Heterozygosity at the p53 Locus in Carcinogenesis of Esophageal Squamous Cell Carcinomas Associated with p53 Mutations

Saeki, H., Kitao, H., Yoshinaga, K., Nakanoko, T., Kubo, N., Kakeji, Y., Morita, M., & Maehara, Y. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1996 · Cited by 43 · see citing works

MDA-MB-435: The questionable use of a melanoma cell line as a model for human breast cancer is ongoing

Christgen, M., & Lehmann, U. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.9.4624 · Cited by 41 · see citing works

Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?

Hollestelle, A., & Schutte, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2396 · Cited by 38 · see citing works

Recommendations for Analyzing and ReportingTP53Gene Variants in the High-Throughput Sequencing Era

Soussi, T., Leroy, B., & Taschner, P. E. M. (2014) · Human Mutation · doi:10.1002/humu.22561 · Cited by 36 · see citing works

The DU145 human prostate carcinoma cell line harbors a temperature-sensitive allele of p53

Bajgelman, M. C., & Strauss, B. E. (2006) · The Prostate · doi:10.1002/pros.20462 · Cited by 36 · see citing works

K‐ras and p53 Alterations in Genomic DNA and Transcripts of Human Pancreatic Adenocarcinoma Cell Lines

Suwa, H., Yoshimura, T., Yamaguchi, N., Kanehira, K., Manabe, T., Imamura, M., Hiai, H., & Fukumoto, M. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02898.x · Cited by 32 · see citing works

Detecting p53 Isoforms at Protein Level

Marcel, V., Khoury, M. P., Fernandes, K., Diot, A., Lane, D. P., & Bourdon, J.-C. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-236-0_2 · Cited by 22 · see citing works

Correlation between DNA alterations and p53 and p16 protein expression in cancer cell lines

Murai, Y., Hayashi, S., Takahashi, H., Tsuneyama, K., & Takano, Y. (2005) · Pathology - Research and Practice · doi:10.1016/j.prp.2005.01.002 · Cited by 22 · see citing works

Detecting and Quantifying p53 Isoforms at mRNA Level in Cell Lines and Tissues

Khoury, M. P., Marcel, V., Fernandes, K., Diot, A., Lane, D. P., & Bourdon, J. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-236-0_1 · Cited by 20 · see citing works

Persistent use of misidentified cell lines and its prevention

MacLeod, R. A. F., Dirks, W. G., & Drexler, H. G. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1217 · Cited by 20 · see citing works

Advances in carcinogenesis: A historical perspective from observational studies to tumor genome sequencing and TP53 mutation spectrum analysis

Soussi, T. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.07.003 · Cited by 20 · see citing works

Analysis of p53 status in human cell lines using a functional assay in yeast: Detection of new non-sense p53 mutation in codon 124

Šmardová, J., Pavlová, Š., Svitáková, M., Grochová, D., & Ravčuková, B. (2005) · Oncology Reports · doi:10.3892/or.14.4.901 · Cited by 18 · see citing works

Comparison of Molecular Changes in Cervical Intraepithelial Neoplasia in HIV-Positive and HIV-Indeterminate Subjects

Wistuba, I. I., Syed, S., Behrens, C., Duong, M., Milchgrub, S., Muller, C. Y., Jagirdar, J. S., & Gazdar, A. F. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5485 · Cited by 17 · see citing works

Gamma irradiation of human leukaemic cells HL-60 and MOLT-4 induces decrease in Mcl-1 and Bid, release of cytochrome c, and activation of caspase-8 and caspase-9

Tichý, A., Záškodová, D., Pejchal, J., Řezáčová, M., Österreicher, J., Vávrová, J., & Cerman, J. (2008) · International Journal of Radiation Biology · doi:10.1080/09553000802078404 · Cited by 10 · see citing works

Autophagy in malignant transformation and cancer progression

Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182 · see citing works

Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

Knijnenburg, T., Wang, L., Zimmermann, M. T., Chambwe, N., Gao, G. F., Cherniack, A. D., Fan, H., Shen, H., Way, G. P., Greene, C. S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.076 · Cited by 1,126 · see citing works

Ki-67: more than a proliferation marker

Sun, X., & Kaufman, P. D. (2018) · Chromosoma · doi:10.1007/s00412-018-0659-8 · Cited by 963 · see citing works

TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade

Leroy, B., Anderson, M., & Soussi, T. (2014) · Human Mutation · doi:10.1002/humu.22552 · Cited by 412 · see citing works

The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies

Molina, D. M., & Nordlund, P. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103715 · Cited by 307 · see citing works

CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space

Korbecki, J., Barczak, K., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020792 · Cited by 155 · see citing works

Over-elongation of centrioles in cancer promotes centriole amplification and chromosome missegregation

Marteil, G., Guerrero, A., Vieira, A. F., de Almeida, B. P., Machado, P., Mendonça, S., Mesquita, M., Villarreal, B., Fonseca, I., Francia, M. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03641-x · Cited by 142 · see citing works

Evolutionary trajectories of small cell lung cancer under therapy

George, J., Maas, L., Abedpour, N., Cartolano, M., Kaiser, L., Fischer, R. N., Scheel, A. H., Weber, J.-P., Hellmich, M., Bosco, G., et al. (2024) · Nature · doi:10.1038/s41586-024-07177-7 · Cited by 137 · see citing works

The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling

Chen, B., Dragomir, M. P., Fabris, L., Bayraktar, R., Knutsen, E., Liu, X., Tang, C., Li, Y., Shimura, T., Ivković, T. C., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.018 · Cited by 129 · see citing works

A Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle Progression

Newell, M., Baker, K., Postovit, L.-M. M., & Field, C. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081784 · Cited by 121 · see citing works

Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells

Göbel, A., Breining, D., Rauner, M., Hofbauer, L. C., & Rachner, T. D. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1322-x · Cited by 117 · see citing works

The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy

Nakamura, M., Obata, T., Daikoku, T., & Fujiwara, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215482 · Cited by 99 · see citing works

Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?Preprint

da Costa, D. C. F., de Oliveira, G. A. P., Cino, E. A., Soares, I. N., Rangel, L. P., & Silva, J. L. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023614 · Cited by 89 · see citing works

Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28

Müller, I., Strozyk, E. A., Schindler, S., Beissert, S., Oo, H. Z., Sauter, T., Lucarelli, P., Raeth, S., Haußer, A., Nakouzi, N. A., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.023 · Cited by 84 · see citing works

Rapid recruitment of p53 to DNA damage sites directs DNA repair choice and integrity

Wang, Y., Ho, T. L. F., Hariharan, A., Goh, H. C., Wong, Y. L., Verkaik, N. S., Lee, M. Y., Tam, W. L., van Gent, D. C., Venkitaraman, A. R., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113233119 · Cited by 87 · see citing works

A Group of Novel HIF‐1α Inhibitors, Glyceollins, Blocks HIF‐1α Synthesis and Decreases Its Stability via Inhibition of the PI3K/AKT/mTOR Pathway and Hsp90 Binding

Lee, S., Jee, J., Bae, J., Liu, K., & Lee, Y. M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24813 · Cited by 86 · see citing works

The lncRNA SLNCR Recruits the Androgen Receptor to EGR1-Bound Genes in Melanoma and Inhibits Expression of Tumor Suppressor p21

Schmidt, K., Carroll, J. S., Yee, E., Thomas, D. D., Wert-Lamas, L., Neier, S. C., Sheynkman, G., Ritz, J., & Novina, C. D. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.101 · Cited by 85 · see citing works

MITF reprograms the extracellular matrix and focal adhesion in melanoma

Dilshat, R., Fock, V., Kenny, C., Gerritsen, I., Lasseur, R. M. J., Trávníčková, J., Eichhoff, O. M., Cerny, P., Möller, K., Sigurbjörnsdóttir, S., et al. (2021) · eLife · doi:10.7554/elife.63093 · Cited by 82 · see citing works

Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma

Tornín, J., Mateu‐Sanz, M., Rodríguez, A., Labay, C., Rodrı́guez, R., & Canal, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-47128-1 · Cited by 81 · see citing works

Molecular Pathways Involved in the Anti-Cancer Activity of Flavonols: A Focus on Myricetin and Kaempferol

Felice, M. R., Maugeri, A., Sarro, G. D., Navarra, M., & Barreca, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084411 · Cited by 76 · see citing works

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis

Chou, C.-W., Lin, C., Hsiao, T.-H., Lo, C.-C., Hsieh, C.-Y., Huang, C.-C., & Sher, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-56532-6 · Cited by 60 · see citing works

The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival

He, Y., Wang, S., Tong, J., Jiang, S., Yang, Y., Zhang, Z., Xu, Y., Zeng, Y., Cao, B., Moran, M. F., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010724 · Cited by 55 · see citing works

Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets

Zięba, S., Kowalik, A., Zalewski, K., Rusetska, N., Goryca, K., Piaścik, A., Misiek, M., Bakuła‐Zalewska, E., Kopczyński, J., Kowalski, K., et al. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.06.026 · Cited by 57 · see citing works

Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression—An in vitro study

Ayyagari, V. N., Wang, X., Díaz‐Sylvester, P., Groesch, K. A., & Brard, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228024 · Cited by 57 · see citing works

Mutant p53 oncogenicity: dominant-negative or gain-of-function?

Stein, Y., Aloni-Grinstein, R., & Rotter, V. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa117 · Cited by 60 · see citing works

Cold Atmospheric Plasma: A New Strategy Based Primarily on Oxidative Stress for Osteosarcoma Therapy

Mateu‐Sanz, M., Tornín, J., Ginebra, M., & Canal, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040893 · Cited by 57 · see citing works

Improved Autophagic Flux in Escapers from Doxorubicin-Induced Senescence/Polyploidy of Breast Cancer Cells

Bojko, A., Staniak, K., Czarnecka‐Herok, J., Sunderland, P., Dudkowska, M., Śliwińska, M. A., Salmiņa, K., & Sikora, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176084 · Cited by 55 · see citing works

Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells

Pò, A., Citarella, A., Catanzaro, G., Besharat, Z. M., Trocchianesi, S., Gianno, F., Sabato, C., Moretti, M., Smaele, E. D., Vacca, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70871-9 · Cited by 54 · see citing works

Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research

Witt, B. L., & Tollefsbol, T. O. (2023) · Life · doi:10.3390/life13122311 · Cited by 54 · see citing works

A Systematic Analysis Reveals Heterogeneous Changes in the Endocytic Activities of Cancer Cells

Elkin, S. R., Bendris, N., Reis, C. R., Zhou, Y., Xie, Y., Huffman, K. E., Minna, J. D., & Schmid, S. L. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0939 · Cited by 54 · see citing works

Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer

de Oliveira, G. A. P., Rangel, L. P., da Costa, D. C. F., & Silva, J. L. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00097 · Cited by 55 · see citing works

Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines

Patiño-Morales, C. C., Soto‐Reyes, E., Aréchaga-Ocampo, E., Ortíz-Sánchez, E., Antonio-Véjar, V., Pedraza‐Chaverrí, J., & García-Carrancá, A. M. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101320 · Cited by 50 · see citing works

Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage

Zerdoumi, Y., Lanos, R., Raad, S., Flaman, J., Bougeard, G., Frébourg, T., & Tournier, I. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx106 · Cited by 49 · see citing works

Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1

Wright, D. G., Marchal, C., Hoang, K., Ankney, J. A., Nguyen, S. T., Rushing, A. W., Polakowski, N. J., Miotto, B., & Lemasson, I. (2015) · Oncotarget · doi:10.18632/oncotarget.6424 · Cited by 44 · see citing works

Low dose of zearalenone elevated colon cancer cell growth through G protein-coupled estrogenic receptor

Lo, E. K. K., Lee, J. C., Turner, P. C., & El-Nezami, H. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-86788-w · Cited by 44 · see citing works

Linalool inhibits 22Rv1 prostate cancer cell proliferation and induces apoptosis

Zhao, Y., Cheng, X., Wang, G., Liao, Y., & Qing, C. (2020) · Oncology Letters · doi:10.3892/ol.2020.12152 · Cited by 45 · see citing works

Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status

Patyka, M., Sharifi, Z., Petrecca, K., Mansure, J., Jean-Claude, B., & Sabri, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11197 · Cited by 42 · see citing works

Calotropis gigantea extract induces apoptosis through extrinsic/intrinsic pathways and reactive oxygen species generation in A549 and NCI-H1299 non-small cell lung cancer cells

Lee, J., Jang, H.-J., Chun, H., Pham, T., Bak, Y., Shin, J.-W., Jin, H., Kim, Y., Ryu, H. W., Oh, S., et al. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2561-1 · Cited by 42 · see citing works

The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia

Chang, Y., Keramatnia, F., Ghate, P. S., Nishiguchi, G., Gao, Q., Iacobucci, I., Yang, L., Chepyala, D., Mishra, A., High, A. A., et al. (2023) · Blood · doi:10.1182/blood.2022017813 · Cited by 41 · see citing works

Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma

Nayak, S., Aich, M., Kumar, A., Sengupta, S., Bajad, P., Dhapola, P., Paul, D., Narta, K., Purkrait, S., Mehani, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26000-8 · Cited by 39 · see citing works

Combined p53- and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer

Gasparyan, M., Lo, M., Jiang, H., Lin, C.-C. A., & Sun, D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010710 · Cited by 39 · see citing works

TFAP2 paralogs facilitate chromatin access for MITF at pigmentation and cell proliferation genes

Kenny, C., Dilshat, R., Seberg, H., Otterloo, E. V., Bonde, G., Helverson, A., Franke, C. M., Steingrı́msson, E., & Cornell, R. A. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010207 · Cited by 39 · see citing works

Twist1 induces chromosomal instability (CIN) in colorectal cancer cells

Khot, M., Sreekumar, D., Jahagirdar, S., Kulkarni, A. M., Hari, K., Faseela, E. E., Sabarinathan, R., Jolly, M. K., & Sengupta, K. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa076 · Cited by 38 · see citing works

Mad1 destabilizes p53 by preventing PML from sequestering MDM2

Wan, J., Block, S., Scribano, C. M., Thiry, R., Esbona, K., Audhya, A., & Weaver, B. A. A. (2019) · Nature Communications · doi:10.1038/s41467-019-09471-9 · Cited by 37 · see citing works

Olig2 SUMOylation protects against genotoxic damage response by antagonizing p53 gene targeting

Liu, H., Weng, W., Guo, R., Zhou, J., Xue, J., Zhong, S., Cheng, J., Zhu, M. X., Pan, S.-J., & Li, Y. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0569-1 · Cited by 37 · see citing works

Recommendations for Analyzing and ReportingTP53Gene Variants in the High-Throughput Sequencing Era

Soussi, T., Leroy, B., & Taschner, P. E. M. (2014) · Human Mutation · doi:10.1002/humu.22561 · Cited by 36 · see citing works

PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer

Martincuks, A., Song, J., Kohut, A. Y., Zhang, C., Li, Y., Zhao, Q., Mak, E., Rodrı́guez-Rodrı́guez, L., Yu, H., & Cristea, M. C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.724104 · Cited by 37 · see citing works

The serological responses to acute exercise in humans reduce cancer cell growth in vitro: A systematic review and meta‐analysis

Orange, S. T., Jordan, A., & Saxton, J. (2020) · Physiological Reports · doi:10.14814/phy2.14635 · Cited by 35 · see citing works

The Expression and Correlation of iNOS and p53 in Oral Squamous Cell Carcinoma

Yang, L., Wang, Y., Guo, L., Wang, L., Chen, W., & Shi, B. (2015) · BioMed Research International · doi:10.1155/2015/637853 · Cited by 33 · see citing works

AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain

Costa-Verdera, H., Meneghini, V., Fitzpatrick, Z., Abou Alezz, M., Fabyanic, E., Huang, X., Dzhashiashvili, Y., Ahiya, A., Mangiameli, E., Valeri, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58778-3 · Cited by 32 · see citing works

CellExpress: a comprehensive microarray-based cancer cell line and clinical sample gene expression analysis online system

Lee, Y.-F., Lee, C., Lai, L., Tsai, M., Lu, T., & Chuang, E. Y.-Y. (2017) · Database · doi:10.1093/database/bax101 · Cited by 32 · see citing works

IGFBP-3 Blocks Hyaluronan-CD44 Signaling, Leading to Increased Acetylcholinesterase Levels in A549 Cell Media and Apoptosis in a p53-Dependent Manner

Price, D., Muterspaugh, R., Clegg, B., Williams, A., Stephens, A., Guthrie, J. W., Heyl, D., & Evans, H. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-61743-3 · Cited by 32 · see citing works

Detection of large deletion in human BRCA1 gene in human breast carcinoma MCF-7 cells by using DNA-Silver Nanoclusters

Borghei, Y.-S., Hosseini, M., & Ganjali, M. (2017) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/aa8988 · Cited by 26 · see citing works

An RNA guanine quadruplex regulated pathway to TRAIL-sensitization by DDX21

McRae, E. K. S., Dupas, S. J., Booy, E. P., Piragasam, R. S., Fahlman, R. P., & McKenna, S. A. (2019) · RNA · doi:10.1261/rna.072199.119 · Cited by 31 · see citing works

Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic

Al-Mansour, F. S. H., Alraddadi, A. M., He, B., Saleh, A., Poblocka, M., Alzahrani, W., Cowley, S. M., & Macip, S. (2023) · Aging · doi:10.18632/aging.204616 · Cited by 30 · see citing works

Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer

Hasim, M. S., Nessim, C., Villeneuve, P. J., Vanderhyden, B. C., & Dimitroulakos, J. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.06.001 · Cited by 30 · see citing works

Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53 -Dependent Manner

McDonald, J. I., Diab, N., Arthofer, E., Hadley, M. M., Kanholm, T., Rentia, U., Gomez, S., Yu, A. Y. C., Grundy, E. E., Cox, O. L., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4243 · Cited by 30 · see citing works

Direct measurement of engineered cancer mutations and their transcriptional phenotypes in single cells

Kim, H. S., Grimes, S. M., Chen, T., Sathe, A., Lau, B. T., Hwang, G., Bae, S., & Ji, H. P. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01949-8 · Cited by 31 · see citing works

Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51

Turdo, A., Gaggianesi, M., Franco, S. D., Veschi, V., D’Accardo, C., Porcelli, G., Iacono, M. L., Pillitteri, I., Verona, F., Militello, G., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02239-4 · Cited by 29 · see citing works

Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer

Raab, M., Kostova, I., Peña‐Llopis, S., Fietz, D., Kressin, M., Aberoumandi, S. M., Ullrich, E., Becker, S., Sanhaji, M., & Strebhardt, K. (2023) · 癌症：英文版 · doi:10.1002/cac2.12511 · Cited by 27 · see citing works

Lapcin, a potent dual topoisomerase I/II inhibitor discovered by soil metagenome guided total chemical synthesis

Wang, Z., Forelli, N., Hernandez, Y. A., Ternei, M. A., & Brady, S. F. (2022) · Nature Communications · doi:10.1038/s41467-022-28292-x · Cited by 27 · see citing works

Alkannin-Induced Oxidative DNA Damage Synergizes With PARP Inhibition to Cause Cancer-Specific Cytotoxicity

Ming-xin, C., Wang, H., Niu, J., Song, Y., & Zou, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.610205 · Cited by 26 · see citing works

MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma

Fu, D., Pfannenstiel, L., Demelash, A., Phoon, Y. P., Mayell, C., Cabrera, C., Liu, C., Zhao, J., Dermawan, J. K. T. K., Patil, D. T., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-021-04334-y · Cited by 26 · see citing works

miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosis

Shi, C., Rao, C., Sun, C., Yu, L., Zhou, X., Hua, D., Wang, R., Luo, W., Jiang, Z., Zhou, J., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1092-x · Cited by 25 · see citing works

Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer

Dean, M., Jin, V., Russo, A., Lantvit, D. D., & Burdette, J. E. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy170 · Cited by 25 · see citing works

A systematic review and meta-analysis of topoisomerase inhibition in pre-clinical glioma models

Jue, T. R., Sena, E. S., Macleod, M. R., McDonald, K. L., & Hirst, T. C. (2018) · Oncotarget · doi:10.18632/oncotarget.24334 · Cited by 24 · see citing works

Regulation of amyloid-β levels by matrix metalloproteinase-2/9 (MMP2/9) in the media of lung cancer cells

Dorandish, S., Williams, A., Atali, S., Sendo, S., Price, D., Thompson, C., Guthrie, J., Heyl, D. L., & Evans, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-88574-0 · Cited by 21 · see citing works

Selective targeting p53WT lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA

Lu, W. P., Cheng, F., Yan, W., Li, X., Yao, X., Song, W., Liu, M., Shen, X., Jiang, H., Chen, J., et al. (2017) · Oncogene · doi:10.1038/onc.2017.41 · Cited by 24 · see citing works

Humanin Blocks the Aggregation of Amyloid‑β Induced by Acetylcholinesterase, an Effect Abolished in the Presence of IGFBP‑3

Price, D., Dorandish, S., Williams, A., Iwaniec, B., Stephens, A., Marshall, K., Guthrie, J. W., Heyl, D., & Evans, H. G. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00274 · Cited by 24 · see citing works

Antitumor activity of α‐pinene in T‐cell tumors

Abe, M., Asada, N., Kimura, M., Fukui, C., Yamada, D., Wang, Z., Miyake, M., Takarada, T., Ono, M., Aoe, M., et al. (2024) · Cancer Science · doi:10.1111/cas.16086 · Cited by 22 · see citing works

A membrane transporter determines the spectrum of activity of a potent platinum–acridine hybrid anticancer agent

Yao, X., Watkins, N. H., Brown, H. M., & Bierbach, U. (2020) · Scientific Reports · doi:10.1038/s41598-020-72099-z · Cited by 21 · see citing works

A Novel Set of Cas9 Fusion Proteins to Stimulate Homologous Recombination: Cas9-HRs

Hackley, C. R. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0034 · Cited by 21 · see citing works

Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems–based Resource

Morris, J., Kunkel, M. W., White, S. L., Wishka, D. G., Lopez, O. D., Bowles, L., Brady, P. S., Ramsey, P., Grams, J., Rohrer, T. N., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0267 · Cited by 20 · see citing works

Synonymous Somatic Variants in Human Cancer Are Not Infamous: A Plea for Full Disclosure in Databases and Publications

Soussi, T., Taschner, P. E. M., & Samuels, Y. (2016) · Human Mutation · doi:10.1002/humu.23163 · Cited by 21 · see citing works

Microarray gene expression profiling in colorectal (HCT116) and hepatocellular (HepG2) carcinoma cell lines treated withMelicope ptelefolialeaf extract reveals transcriptome profiles exhibiting anticancer activity

Kabir, M. F., Ali, J. M., & Hashim, O. H. (2018) · PeerJ · doi:10.7717/peerj.5203 · Cited by 21 · see citing works

Interaction of amyloid beta with humanin and acetylcholinesterase is modulated by ATP

Atali, S., Dorandish, S., Devos, J., Williams, A., Price, D., Taylor, J. E., Guthrie, J. W., Heyl, D., & Evans, H. G. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.13023 · Cited by 21 · see citing works

RNAi Screening-based Identification of USP10 as a Novel Regulator of Paraptosis

Kim, J. Y., Lee, D. M., Woo, H. G., Kim, K. D., Lee, H. J., Kwon, Y., & Choi, K. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-40982-z · Cited by 20 · see citing works

Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer

Wiegmans, A. P., Ward, A., Ivanova, E., Duijf, P. H. G., Adams, M. N., Najib, I. M., Oosterhout, R. V., Sadowski, M. C., Kelly, G., Morrical, S. W., et al. (2021) · NAR Cancer · doi:10.1093/narcan/zcab022 · Cited by 20 · see citing works

Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes

Vymetalkova, V. P., Souček, P., Kunická, T., Jirásková, K., Brynychová, V., Pardini, B., Novosadová, V., Polívková, Z., Kubáčková, K., Koževnikovová, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134463 · Cited by 20 · see citing works

Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA / mRNA expression analysis

Nirgude, S., Desai, S. S., & Choudhary, B. (2022) · Cancer Reports · doi:10.1002/cnr2.1596 · Cited by 19 · see citing works

Differences in the Relative Abundance of ProBDNF and Mature BDNF in A549 and H1299 Human Lung Cancer Cell Media

Dorandish, S., Atali, S., Ray, R., Khashali, H. A., Coleman, K.-L., Guthrie, J. W., Heyl, D., & Evans, H. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137059 · Cited by 19 · see citing works

Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance

Coleman, K.-L., Chiaramonti, M., Haddad, B., Ranzenberger, R., Henning, H., Khashali, H. A., Ray, R., Darweesh, B., Guthrie, J. W., Heyl, D., et al. (2023) · Cells · doi:10.3390/cells12030405 · Cited by 19 · see citing works

Advanced glycation end products (AGE) potentiates cell death in p53 negative cells via upregulaion of NF‐kappa B and impairment of autophagy

Verma, N., & Manna, S. K. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25828 · Cited by 19 · see citing works

WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia

Bordin, F., Piovan, E., Masiero, E., Ambesi‐Impiombato, A., Minuzzo, S. A., Bertorelle, R., Sacchetto, V., Pilotto, G., Basso, G., Zanovello, P., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.170431 · Cited by 19 · see citing works

Nuclear HKII–P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer

Han, C. Y., Patten, D. A., Kim, S. I., Lim, J. Y., Chan, D. W., Siu, M. K. Y., Han, Y., Carmona, E., Parks, R. J., Lee, C., et al. (2021) · Cancers · doi:10.3390/cancers13143399 · Cited by 18 · see citing works

A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas

Molinaro, C., Wambang, N., Bousquet, T., Vercoutter‐Edouart, A., Pélinski, L., Cailliau, K., & Martoriati, A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.837373 · Cited by 18 · see citing works

Global and single-cell proteomics view of the co-evolution between neural progenitors and breast cancer cells in a co-culture model

Bjørnstad, O. V., Carrasco, M., Finne, K., Ardawatia, V. V., Winge, I., Askeland, C., Arnes, J. B., Knutsvik, G., Kleftogiannis, D., Paulo, J. A., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105325 · Cited by 18 · see citing works

TheTP53Gene Network in a Postgenomic Era

Soussi, T. (2014) · Human Mutation · doi:10.1002/humu.22562 · Cited by 17 · see citing works

Role of Δ133p53 isoform in NF-κB inhibitor PDTC-mediated growth inhibition of MKN45 gastric cancer cells

Zhang, H., Sang, X.-G., Wang, Y.-Z., Cui, C., Zhang, L., & Ji, W. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i15.2716 · Cited by 17 · see citing works

Oleandrin sensitizes human osteosarcoma cells to cisplatin by preventing degradation of the copper transporter 1

Lei, Y. H., Ma, Y., Liang, C., He, G., Zhao, Z., Yang, C., Hai, B., Pan, X., Liu, Z., & Liu, X. (2019) · Phytotherapy Research · doi:10.1002/ptr.6373 · Cited by 17 · see citing works

Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance

Chu, S., & Stochaj, U. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.20 · Cited by 17 · see citing works

Erianthridin Induces Non-small Cell Lung Cancer Cell Apoptosis through the Suppression of Extracellular Signal-regulated Kinase Activity

Boonjing, S., Pothongsrisit, S., Wattanathamsan, O., Sritularak, B., & Pongrakhananon, V. (2020) · Planta Medica · doi:10.1055/a-1295-8606 · Cited by 17 · see citing works

CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis

Mohanty, S., Mohapatra, P., Shriwas, O., Ansari, S. A., Priyadarshini, M., Priyadarsini, S., Rath, R., Sultania, M., Majumdar, S. K. D., Swain, R. K., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02475-8 · Cited by 16 · see citing works

PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma

Simoni, M., Menegazzi, C., Fracassi, C., Biffi, C. C., Genova, F., Tenace, N. P., Lucianò, R., Raimondi, A., Tacchetti, C., Brugarolas, J., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00077-3 · Cited by 18 · see citing works

The natural cytokinin 2OH3MeOBAR induces cell death by a mechanism that is different from that of the “classical” cytokinin ribosides

Voller, J., Béreš, T., Zatloukal, M., Kaminski, P. A., Niemann, P., Doležal, K., Džubák, P., Hajdúch, M., & Strnad, M. (2017) · Phytochemistry · doi:10.1016/j.phytochem.2017.01.004 · Cited by 16 · see citing works

TP53 somatic mutations in Asian breast cancer are associated with subtype-specific effects

Ragu, M. E., Lim, J., Ng, P.-S., Yip, C. H., Rajadurai, P., Teo, S., & Pan, J. W. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01635-2 · Cited by 15 · see citing works

Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations—Possible Therapeutic Efficacy of Cabozantinib

Ko, Y.-C., Hu, C., Liu, Z.-H., Tien, H., Ou, D., Chien, H., & Lin, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051230 · Cited by 15 · see citing works

The Use of Human Tissues for Research: What Investigators Need to Know

Bledsoe, M. J., & Grizzle, W. E. (2022) · Alternatives to Laboratory Animals · doi:10.1177/02611929221107933 · Cited by 15 · see citing works

The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer

Asare-Werehene, M., Hunter, R., Gerber, E., Reunov, A., Brine, I., Chang, C.-Y., Chang, C., Shieh, D., Burger, D. E., Anis, H., et al. (2023) · Cancers · doi:10.3390/cancers15092566 · Cited by 14 · see citing works

Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination

Berglind, H., Yudi Pawitan, Y., Kato, S., Ishioka, C., & Soussi, T. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.5.5712 · Cited by 102 · see citing works

[Characterization of TP53, APC, and PTEN mutational statuses of 120 human cancer cell lines by using yeast-based analyses].

Suzuki, G. (2003) · PubMed · Cited by 3 · see citing works

MUT-TP53 2.0: a novel versatile matrix for statistical analysis of TP53 mutations in human cancera

Soussi, T., Hamroun, D., Hjortsberg, L., Rubio-Nevado, J. M., Fournier, J. L., & Béroud, C. (2010) · Human Mutation · doi:10.1002/humu.21313 · Cited by 27 · see citing works

The TP53 website: An integrative resource centre for the TP53 mutation database and TP53 mutant analysis

Leroy, B., Fournier, J. L., Ishioka, C., Monti, P., Inga, A., Fronza, G., & Soussi, T. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1033 · Cited by 185 · see citing works

Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines

Liu, Y., & Bodmer, W. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510146103 · Cited by 257 · see citing works